N-(2-Fluorophenyl)-4-(6-(4-(4-methylpiperazin-1-yl)-phenyl)thieno[2,3-d]pyrimidin-4-yl)piperazine-1-carboxamide

ID: ALA4858075

PubChem CID: 164610912

Max Phase: Preclinical

Molecular Formula: C28H30FN7OS

Molecular Weight: 531.66

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccccc6F)CC5)ncnc4s3)cc2)CC1

Standard InChI:  InChI=1S/C28H30FN7OS/c1-33-10-12-34(13-11-33)21-8-6-20(7-9-21)25-18-22-26(30-19-31-27(22)38-25)35-14-16-36(17-15-35)28(37)32-24-5-3-2-4-23(24)29/h2-9,18-19H,10-17H2,1H3,(H,32,37)

Standard InChI Key:  VTQFSAWJAUSJLB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   16.4883  -29.0887    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7825  -29.5014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7825  -30.3227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4919  -30.7313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2013  -30.3227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2013  -29.5014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4919  -31.5518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7780  -31.9598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7780  -32.7804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4901  -33.1939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2011  -32.7746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2011  -31.9576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9765  -31.7009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4591  -32.3592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9859  -33.0203    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   19.2773  -32.3592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6945  -33.0656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5151  -33.0656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9194  -32.3448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5013  -31.6336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6821  -31.6336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7365  -32.3365    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.1465  -33.0397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9601  -33.0334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3654  -32.3234    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9509  -31.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1311  -31.6227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1826  -32.3182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4865  -28.2715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1932  -27.8613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7778  -27.8645    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9019  -28.2684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8989  -29.0857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6067  -29.4926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3144  -29.0824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3100  -28.2609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6016  -27.8577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5962  -27.0405    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 12 11  2  0
 12  7  1  0
 13 12  1  0
 14 13  2  0
 15 14  1  0
 11 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
  1 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 32  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4858075

    ---

Associated Targets(Human)

FLT4 Tclin Vascular endothelial growth factor receptor 3 (3216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-436 (532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 531.66Molecular Weight (Monoisotopic): 531.2217AlogP: 4.60#Rotatable Bonds: 4
Polar Surface Area: 67.84Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.42CX Basic pKa: 7.84CX LogP: 4.72CX LogD: 4.14
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.42Np Likeness Score: -2.09

References

1. Li Y, Yang G, Zhang J, Tang P, Yang C, Wang G, Chen J, Liu J, Zhang L, Ouyang L..  (2021)  Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer.,  64  (16.0): [PMID:34351741] [10.1021/acs.jmedchem.1c00678]

Source